secwatch.observer — SEC 8-K summary
======================================

Issuer:     Azitra, Inc. (AZTR)
CIK:        0001701478
Form:       8-K
Filed at:   2026-03-23T23:59:59+00:00
Accession:  0001493152-26-012084
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 3.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Azitra raises $10.5M initial PIPE, up to $31.4M with warrants, for cosmetic protein program
--------------------------------------------------------------------------------

- Initial gross proceeds of ~$10.5M from sale of Series A preferred & warrants; potential additional ~$20.9M if warrants exercised.
- Warrants exercisable at $0.123/share; Series B warrants expire 18 months after stockholder approval; Series C upon data announcement.
- Proceeds to fund R&D for filaggrin protein/peptide cosmetic program targeting $2.3B market growing to $3.7B by 2030.
- Insiders including CEO participated; Stonepine Capital and Nantahala Capital among investors.
- Company must seek stockholder approval for conversion of preferred shares into common; registration rights agreement filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1701478/000149315226012084/0001493152-26-012084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1701478/000149315226012084/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-012084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer